Postnificent t1_jdaqat4 wrote on March 23, 2023 at 1:12 AM

Psilocybin works wonders. It’s also schedule 1 because big pharma can’t turn a profit on something that cures serious permanent issues now can it? If they ever release a version it will be diluted and used for maintenance while you can grow it yourself for next to nothing.

technofuture8 t1_jdcview wrote on March 23, 2023 at 2:21 PM

Actually the main problem is, is that big pharma can't patent psilocybin. Psilocybin can't be patented and that's the problem.

Postnificent t1_jddedap wrote on March 23, 2023 at 4:24 PM

It’s even deeper than that, it would really hurt the antidepressant market. They would rather do maintenance forever than cure a single person. Providing a cure to non deadly lifetime ailments isn’t the most profitable thing. How do you even value something like that? Whatever it is it’s going to cause backlash and they damn well know it. So the prudent course is to keep this life changing medication Federally on the same level as crack (I think the DEA has opened themselves to a lawsuit on this one as they have admitted it is medicine and non addictive yet it remains schedule 1 contrary to their own admission)

technofuture8 t1_jdejmas wrote on March 23, 2023 at 8:44 PM

No my friend, if big pharma can't patent it then they have no interest in it.